# The Human Medicines Regulations 2012, Regulation A17: Interpretation


In this Part “manufacture”, in relation to an active substance, includes any process carried out in the course of making the substance and the various processes of dividing up, packaging, and presentation of the active substance.

---
Source: https://www.legislation.gov.uk/uksi/2012/1916/regulation/A17 (the official version)
Page: https://openlegislation.uk/human-medicines-regulations-2012/regulation-A17
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.